Detalhe da pesquisa
1.
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.
Nature;
629(8011): 426-434, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38658764
2.
The learning curve for the second generation of laparoscopic surgeons: lesson learned from a large series of laparoscopic adrenalectomies.
Surg Endosc;
35(6): 2914-2920, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32556777
3.
Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis.
J Allergy Clin Immunol Glob;
3(1): 100195, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38187863
4.
Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
J Immunol;
184(10): 5895-902, 2010 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20385879
5.
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.
Clin Dev Immunol;
2012: 931952, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22319542
6.
Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer.
Cancer Immunol Immunother;
60(11): 1639-45, 2011 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21833593
7.
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.
Cancer Cell;
39(12): 1623-1642.e20, 2021 12 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34739845
8.
Impact of γ-chain cytokines on EBV-specific T cell cultures.
J Transl Med;
8: 121, 2010 Nov 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21092174
9.
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders.
Haematologica;
95(10): 1769-77, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20421267
10.
TIE-2 expressing monocytes in human cancers.
Oncoimmunology;
6(4): e1303585, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28507810
11.
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.
Oncoimmunology;
6(4): e1304338, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28507812
12.
TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer.
Oncoimmunology;
5(2): e1073882, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27057438
13.
Bone marrow-derived cells are implicated as a source of lymphatic endothelial progenitors in human breast cancer.
Oncoimmunology;
3: e29080, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25101222
14.
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).
PLoS One;
8(11): e80456, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24303016
15.
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.
Clin Cancer Res;
18(15): 4080-91, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22705988
16.
Immunotherapy for EBV-associated malignancies.
Int J Hematol;
93(3): 281-293, 2011 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21336546
17.
Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.
Int Rev Immunol;
29(4): 371-402, 2010 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20635880
18.
Adoptive cell therapy against EBV-related malignancies: a survey of clinical results.
Expert Opin Biol Ther;
8(9): 1265-94, 2008 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18694349